HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Annual Report for the fiscal year ended December 31, 2011 on Form 20-F, filed with the Securities and Exchange Commission (the “SEC”) on April 5, 2012, is available within the Investor Relations section of Taro’s website at www.taro.com. Hard copies of the report may be ordered free of charge by sending requests to Taro Pharmaceuticals U.S.A., Inc., 3 Skyline Drive, Hawthorne, NY 10532, attention: William J. Coote or via email to William.Coote@Taro.com.
